Real world evaluation of the smoking cessation services in the Rio de Janeiro municipality, Brazil

Casado, Letícia; Thuler, Luiz Cláudio Santos

doi:10.1111/jep.12717

Cited by 1 publication

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Considering that it is less costly to help tobacco users to quit than to treat the tobaccorelated diseases, smoking cessation is one of the most relevant health interventions [7]. Studies have shown the effectiveness of pharmaceutical services for smoking cessation [8][9][10].…”

Section: Introductionmentioning

confidence: 99%

Assessment of Pharmaceutical Services for Smoking Cessation: An Effectiveness–Implementation Hybrid Study

Laborne-e-Valle

Ahouagi

Braga

et al. 2022

IJERPH

View full text Add to dashboard Cite

Smoking is the main preventable cause of illness and early death worldwide. Thus, it is better to promote smoking cessation than to treat tobacco-related diseases. The objective of this study was to assess the implementation and effectiveness of smoking cessation pharmaceutical services offered in primary health care (PHC) in a large Brazilian city through a type 1 effectiveness–implementation hybrid study. The services were offered through individual or group approaches (Jan/2018–Dec/2019). The service indicators were described and the incidence of cessation in the services was evaluated. Factors associated with cessation were assessed by Poisson regression analysis. The services were offered in most PHC centers (61.2%) and by most pharmacists (81.3%). In total, 170 individual (9.7%) and 1591 group (90.3%) approaches occurred, leading to cessation in 39.4% (n = 67) and 44.8% (n = 712) of these, respectively. The use of nicotine plus antidepressants (RR = 1.30; 95%CI = 1.08–1.57; p = 0.006) and the number of sessions with pharmacists (RR = 1.21; 95%CI = 1.19–1.23; p < 0.001) were positively associated with cessation; a very high level of dependence was negatively associated (RR = 0.77; 95%CI = 0.67–0.89; p = 0.001). The smoking cessation services were effective and should be encouraged.

show abstract

Section: Introductionmentioning

confidence: 99%

Assessment of Pharmaceutical Services for Smoking Cessation: An Effectiveness–Implementation Hybrid Study

Laborne-e-Valle

Ahouagi

Braga

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

Real world evaluation of the smoking cessation services in the Rio de Janeiro municipality, Brazil

Abstract: Even though more than 20% of the patients did not attend the first group session, the access to treatment was high, and it was observed that the success rate of those who attended the fourth group session was more than 50%.

Cited by 1 publication

References 23 publications

Assessment of Pharmaceutical Services for Smoking Cessation: An Effectiveness–Implementation Hybrid Study

Assessment of Pharmaceutical Services for Smoking Cessation: An Effectiveness–Implementation Hybrid Study

Contact Info

Product

Resources

About